About the Bioengineered Organ Initiative

The vision of the Bioengineered Organs Initiative is to save lives by increasing the amount of organs available to patients in need. The multi-disciplinary research team is designing, creating, and testing a new generation of long-term replacement organs engineered from a combination of bioprinted cellular and synthetic materials. This lifesaving technology has the potential to one day eliminate the current organ transplant waiting list.

Collaborative research at Carnegie Mellon University in 3-D printing, tissue engineering, biomaterials, cellular mechanics, and artificial organs can support or replace diseased organs. These bioengineered organs can improve survival rates for the millions of patients with end-stage organ failure in the United States.

“The human body experiences a powerful gravitational pull in the direction of hope. That is why the patient’s hopes are the physician’s secret weapon. They are the hidden ingredients in any prescription.” Norman Cousins